Treatment for combat-related posttraumatic stress disorder: Two-year follow-up
β Scribed by Mark Creamer; Peter Elliott; David Forbes; Dirk Biddle; Graeme Hawthorne
- Book ID
- 102449443
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 145 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0894-9867
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This study reports on outcomes 2 years following completion of specialist veteran posttraumatic stress disorder (PTSD) treatment programs in 2,223 (reduced to 1,508 at 24 months) consecutive admissions. Selfβreport measures of PTSD, anxiety, depression, anger, alcohol use, and general functioning were obtained at admission, 6, 12, and 24 months after admission. Significant improvements were demonstrated at 6 months, with smaller gains continuing through to 24βmonth assessment. Within subject effect sizes of around 0.8 were obtained for PTSD and around 0.5 for anxiety and depression. Although lack of a control group limits the extent to which improvements can be attributed to the treatment program, the data suggest that specialized treatment programs for combatβrelated PTSD continue to be of value.
π SIMILAR VOLUMES
## Abstract Individuals trained to respond to a potentially traumatic event may not experience the posttraumatic stress disorder (PTSD) A2 diagnostic criterion of fear, helplessness, or horror and yet may still report significant PTSD symptoms. The present study included interviews with 202 soldier
While some recent research has examined the prevalence and severity of posttraumatic stress disorder (PTSD)-like symptoms following cancer treatment, no research has examined temporal change or stability in these symptoms in cancer survivors. Female breast cancer survivors (n=46) participated in an
## Abstract These papers show that longβstay inpatient PTSD programs provide treatment that is quite different from other programs but that they are neither as effective, from a psychometric perspective, nor as helpful, from the veterans' subjective perspective, as has been expected. VA treatment o